RARE vs TSE · rev $350.0M vs rev $3.51B
Ultragenyx (RARE) versus Trinseo SA (TSE) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Trinseo SA (TSE) is a specialty chemicals company listed on NYSE.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported TSE revenue for 2024-12-31 was $3.51B. Net income was -$348.5M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. TSE currently screens at market cap $8.3M.
RARE currently screens at market cap $2.79B. TSE currently screens at market cap $8.3M.
Not investment advice. Open the RARE and TSE stock pages for the full models.
Not investment advice.